Cantargia AB Stock: price and insider trades · Sweden

This page follows insider dealings at Cantargia AB as filed with Finansinspektionen, a company from the Health Care sector. Between 18 October 2025 and 18 October 2026, 18 insiders published 21 filings.

Only purchases show up on the open market, 3 purchases in all worth €31k, filed by 3 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €18k from Hilde Steineger, disclosed on 25 March 2026, or 0.044% of market capitalisation. Among those who bought: 1 board member, 1 finance chief and 1 chief executive.

The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 26 March 2026, 206 days ago. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. The regulation allows three business days to notify a trade (MAR article 19).

For context, the typical company on the same exchange (median of 886 companies) published 7 filings over the same period, against 21 filings here. The full history, which starts in 2021, counts 6 purchases against no sales.

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.